Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) are being widely studied as potential cell therapy agents due to their immunomodulatory properties, which have been established by in vitro studies and in several clinical trials. Within this context, mesenchymal stem cell therapy appears to hold substantial promise, particularly in the treatment of conditions involving autoimmune and inflammatory components. Nevertheless, many research findings are still contradictory, mostly due to difficulties in characterization of the effects of MSCs in vivo. The purpose of this review is to report the mechanisms underlying mesenchymal stem cell therapy for acute graft-versus-host disease, particularly with respect to immunomodulation, migration, and homing, as well as report clinical applications described in the literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364 · cited 3×
“Interleukin 10 (IL-10) Anti-inflammatory [36]”
BackgroundHuman mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767
Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001886 · Cited by 1,610 · cited 1×
“In a CCL3- and CXCL2 (MIP2)-dependent manner, human MSCs recruit monocytes and macrophages from across the body and into inflamed tissues [120].”
BackgroundKinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000118601.37875.ac · Cited by 1,415 · cited 1×
“Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), placental growth factor (PlGF), monocyte chemotactic protein 1 (MCP-1) Increase endothelial cell and smooth muscle cell proliferation [139], [140] Mesenchymal stem cell therapy 143”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
Multilineage differentiation from human embryonic stem cell lines
Odorico, J. S., Kaufman, D. S., & Thomson, J. A. (2001) · Stem Cells · doi:10.1634/stemcells.19-3-193 · Cited by 969 · cited 2×
“Stem cells can be broadly divided into two groups by site of origin: embryonic stem cells (ESCs), which are derived from the inner cell mass of a blastocyst, and adult stem cells (ASCs), which are obtained from umbilical cord blood, bone marrow, or peripheral blood, and present in specific tissues and organs throughou…”
BackgroundInteractions Between Human Mesenchymal Stem Cells and Natural Killer Cells
Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., & Papamichail, M. (2006) · Stem Cells · doi:10.1634/stemcells.2004-0359 · Cited by 956 · cited 6×
“MSCs are also capable of modulating NK cell cytotoxicity by decreasing the amount of cytokines (including IFN-c, IL10, and TNF-a) secreted by NK cells; this phenomenon also requires cell–cell contact [115, 116].”
BackgroundInfluentialMesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages
Kim, J., & Hematti, P. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.09.004 · Cited by 785
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
Spaeth, E., Klopp, A., Dembinski, J., Andreeff, M., & Marini, F. (2008) · Gene Therapy · doi:10.1038/gt.2008.39 · Cited by 579 · cited 1×
“Cell migration depends on a variety of stimulatory or regulatory signals, which range from growth factors to chemokines secreted by damaged cells and/or respondent immune cells [60].”
BackgroundChiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388 · cited 3×
“Stem cells can be broadly divided into two groups by site of origin: embryonic stem cells (ESCs), which are derived from the inner cell mass of a blastocyst, and adult stem cells (ASCs), which are obtained from umbilical cord blood, bone marrow, or peripheral blood, and present in specific tissues and organs throughou…”
BackgroundMesenchymal stem cells induce apoptosis of activated T cells
Plumas, J., Chaperot, L., Richard, M.-J., Molens, J.-P., Bensa, J.-C., & Favrot, M.-C. (2005) · Leukemia · doi:10.1038/sj.leu.2403871 · Cited by 326 · cited 1×
“Induces apoptosis of activated T cells [141]”
Kim, Y. J., Kim, H. K., Cho, H. H., Bae, Y. C., Suh, K. T., & Jung, J. S. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110447 · Cited by 298 · cited 1×
“Matrix metalloproteinases 3 and 9 (MMP3, MMP9) Mediate neovascularization [137]”
BackgroundFang, X., Neyrinck, A. P., Matthay, M. A., & Lee, J. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119917 · Cited by 258
Cited by
Mesenchymal stem cells: Cell therapy and regeneration potential
Brown, C., McKee, C., Bakshi, S., Walker, K., Hakman, E., Halassy, S., Svinarich, D., Dodds, R., Govind, C. K., & Chaudhry, G. R. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2914 · Cited by 609
Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
Fitzsimmons, R. E. B., Mazurek, M. S., Soos, A., & Simmons, C. A. (2018) · Stem Cells International · doi:10.1155/2018/8031718 · Cited by 358
Regmi, S., Pathak, S., Kim, J. O., Yong, C. S., & Jeong, J.-H. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.04.002 · Cited by 314
The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
Zhang, J., Huang, X., Wang, H., Liu, X., Zhang, T., Wang, Y., & Hu, D. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0240-9 · Cited by 310
Saeedi, P., Halabian, R., & Imani Fooladi, A. A. (2019) · Stem Cell Investigation · doi:10.21037/sci.2019.08.11 · Cited by 251
Metadata
- Authors
- Amorin, B., Alegretti, A. P., Valim, V., Pezzi, A., Laureano, A. M., da Silva, M. A. L., Wieck, A., & Silla, L.
- Venue
- Human Cell
- Published
- 2014-06-06
- Volume
- 27
- Issue
- 4
- Pages
- 137-150
- ISSN
- 0914-7470 (ISSN-L)
- 1749-0774
- OpenAlex
- W1985985259
- Cited by
- 133
- References
- 16
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.